Skip to main content

Preliminary Safety Screening of Duke LpxC Inhibitors as Novel Antibiotics Against Gram-Negative Bacteria

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Oct 7, 2015
Award amount: 
$50,000
Organization name: 
Duke University Medical Center
Principal Investigator: 
Thomas, Dennis
Grant program category: 
Research and Equipment Support
Grant program name: 
Technology Enhancement Grant
Region: 
Research Triangle

Duke University Medical Center will conduct toxicity studies for a proprietary family of antibiotic drugs in order to establish a preclinical safety profile to support further development as clinical therapies to treat multi-drug resistant bacterial infections.

Fiscal year: 
2016